- Home
- NRDS vs NXPLW Comparison
NRDS vs NXPLW Comparison
Compare NRDS & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDS
- NXPLW
- Stock Information
- Founded
- NRDS 2009
- NXPLW N/A
- Country
- NRDS United States
- NXPLW United States
- Employees
- NRDS N/A
- NXPLW 166
- Industry
- NRDS EDP Services
- NXPLW Telecommunications Equipment
- Sector
- NRDS Technology
- NXPLW Telecommunications
- Exchange
- NRDS Nasdaq
- NXPLW Nasdaq
- Market Cap
- NRDS N/A
- NXPLW N/A
- IPO Year
- NRDS 2021
- NXPLW N/A
- Fundamental
- Price
- NRDS $9.02
- NXPLW $0.21
- Analyst Decision
- NRDS Buy
- NXPLW
- Analyst Count
- NRDS 5
- NXPLW 0
- Target Price
- NRDS $17.00
- NXPLW N/A
- AVG Volume (30 Days)
- NRDS 511.2K
- NXPLW 6.4K
- Earning Date
- NRDS 04-24-2025
- NXPLW 03-31-2025
- Dividend Yield
- NRDS N/A
- NXPLW N/A
- EPS Growth
- NRDS N/A
- NXPLW N/A
- EPS
- NRDS 0.38
- NXPLW N/A
- Revenue
- NRDS $687,600,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- NRDS $12.65
- NXPLW N/A
- Revenue Next Year
- NRDS $8.37
- NXPLW N/A
- P/E Ratio
- NRDS $24.53
- NXPLW N/A
- Revenue Growth
- NRDS 14.71
- NXPLW 179.89
- 52 Week Low
- NRDS $8.75
- NXPLW $0.25
- 52 Week High
- NRDS $16.45
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- NRDS 32.60
- NXPLW N/A
- Support Level
- NRDS $9.16
- NXPLW N/A
- Resistance Level
- NRDS $9.62
- NXPLW N/A
- Average True Range (ATR)
- NRDS 0.31
- NXPLW 0.00
- MACD
- NRDS 0.18
- NXPLW 0.00
- Stochastic Oscillator
- NRDS 31.03
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.